Rangeley Capital, LLC
Long book
$92.6M
Q1 2026
Positions
133
Top-10 weight
35%
concentration
Last quarter
+14.2%
SPY +14.8%
Turnover
45%
of book per quarter
Strategy in plain words
auto-generated from filingsRangeley Capital, LLC is a diversified fundamental manager, running a $92.6M US long book across 133 positions.
The portfolio is moderately concentrated (top 10 ≈ 35% of the book). The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: DRIVEN BRANDS HOLDINGS INC, PROTHENA CORP PLC, SEAPORT ENTERTAINMENT GROUP, GRINDR INC, DELEK US HOLDINGS INC.
Over the last 6 quarters its long book ran on average 1.7pp per quarter ahead of the S&P 500, beating the index in 3 of 6 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q4 2024
-15.0%
Q1 2025
+9.8%
Q2 2025
+24.1%
Q3 2025
+5.5%
Q4 2025
-0.4%
Q1 2026
+14.2%
Sector allocation
Healthcare 32%
Services media 20%
Financials 10%
Technology 8%
Other 7%
Energy 6%
Communications 5%
Industrials 4%
Long book by quarter
What does Rangeley Capital, own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| DRVN DRIVEN BRANDS HOLDINGS INC | Services media | 625.5K | $7.9M | 8.5% | New |
| PRTA PROTHENA CORP PLC | Healthcare | 449.5K | $4.4M | 4.7% | -14.3% |
| SEG SEAPORT ENTERTAINMENT GROUP | Services media | 153.5K | $3.3M | 3.6% | Held |
| GRND GRINDR INC | Technology | 234.0K | $2.8M | 3.1% | +10.4% |
| DK DELEK US HOLDINGS INC | Energy | 60.0K | $2.7M | 2.9% | -41.2% |
| ARVN ARVINAS INC | Healthcare | 224.0K | $2.4M | 2.6% | -43.4% |
| ABUS ARBUTUS BIOPHARMA CORP | Healthcare | 500.0K | $2.3M | 2.4% | -40.5% |
| ECHO ECHOSTAR CORP-A | Communications | 18.0K | $2.1M | 2.3% | -25.0% |
| LEG LEGGETT & PLATT INC | Other | 213.0K | $2.1M | 2.3% | +56.7% |
| STHO STAR HOLDINGS | Real estate | 274.1K | $2.1M | 2.2% | +46.5% |
| FLL FULL HOUSE RESORTS INC | Services media | 915.6K | $2.1M | 2.2% | +2.2% |
| TRIP TRIPADVISOR INC | Technology | 190.0K | $2.0M | 2.2% | New |
| ICLR ICON PLC | Healthcare | 17.7K | $2.0M | 2.1% | New |
| CLMT CALUMET INC | Energy | 53.0K | $1.9M | 2.1% | -79.6% |
| GDOT GREEN DOT CORP-CLASS A | Financials | 162.7K | $1.8M | 2.0% | New |
| 2KZ0 KEZAR LIFE SCIENCES INC | — | 243.1K | $1.8M | 1.9% | +182.9% |
| JANX JANUX THERAPEUTICS INC | Healthcare | 122.5K | $1.7M | 1.8% | +382.0% |
| TBPH THERAVANCE BIOPHARMA INC | Healthcare | 103.0K | $1.7M | 1.8% | New |
| BHF BRIGHTHOUSE FINANCIAL INC | Financials | 25.0K | $1.5M | 1.6% | Held |
| ZIM ZIM INTEGRATED SHIPPING SERV | Industrials | 55.0K | $1.4M | 1.6% | +34.0% |
| FWRD FORWARD AIR CORP | Industrials | 85.0K | $1.4M | 1.5% | +11.8% |
| WBD WARNER BROS DISCOVERY INC | Communications | 51.0K | $1.4M | 1.5% | -76.4% |
| RVMD REVOLUTION MEDICINES INC | Healthcare | 66.7K | $1.2M | 1.3% | New |
| SWKHL SWK HOLDINGS CORP | Financials | 63.0K | $1.1M | 1.2% | Held |
| HO1 HOLOGIC INC | — | 13.0K | $983K | 1.1% | New |
| HGV HILTON GRAND VACATIONS INC | Services media | 25.0K | $978K | 1.1% | +66.7% |
| SEPN SEPTERNA INC | Healthcare | 39.8K | $956K | 1.0% | -39.5% |
| WENN WEN ACQUISITION CORP-A | Financials | 85.0K | $865K | 0.9% | +35.9% |
| MNRO MONRO INC | Services media | 52.3K | $840K | 0.9% | New |
| KURA KURA ONCOLOGY INC | Healthcare | 101.2K | $823K | 0.9% | -1.6% |
| SEM SELECT MEDICAL HOLDINGS CORP | Healthcare | 50.0K | $815K | 0.9% | -38.3% |
| DRDB ROMAN DBDR ACQUISITION CORP | Financials | 60.0K | $628K | 0.7% | +38.9% |
| KROS KEROS THERAPEUTICS INC | Healthcare | 54.4K | $601K | 0.6% | -43.8% |
| NVRI ENVIRI CORP | Utilities | 28.0K | $549K | 0.6% | +162.5% |
| GLUE MONTE ROSA THERAPEUTICS INC | Healthcare | 27.0K | $444K | 0.5% | -60.0% |
| DSGR DISTRIBUTION SOLUTIONS GROUP | Consumer discretionary | 16.9K | $442K | 0.5% | New |
| OACC OAKTREE ACQUISITION CORP I-A | Financials | 61.2K | $424K | 0.5% | +52.8% |
| CRBP CORBUS PHARMACEUTICALS HOLDI | Healthcare | 44.8K | $421K | 0.5% | New |
| IMMR IMMERSION CORPORATION | Technology | 75.0K | $410K | 0.4% | New |
| OKUR ONKURE THERAPEUTICS INC-A | Healthcare | 95.0K | $393K | 0.4% | -34.5% |
| STRS STRATUS PROPERTIES INC | Real estate | 12.5K | $383K | 0.4% | New |
| YEXT YEXT INC | Technology | 99.3K | $381K | 0.4% | -83.0% |
| ACET ADICET BIO INC | Healthcare | 56.0K | $381K | 0.4% | +124.0% |
| LSTA LISATA THERAPEUTICS INC | Healthcare | 75.0K | $376K | 0.4% | New |
| LNSR LENSAR INC | Healthcare | 63.0K | $375K | 0.4% | +6.8% |
| IKT INHIBIKASE THERAPEUTICS INC | Healthcare | 220.0K | $370K | 0.4% | New |
| FERA FIFTH ERA ACQUISITION CORP-A | Financials | 31.0K | $319K | 0.3% | -7.4% |
| SSP EW SCRIPPS CO/THE-A | Communications | 85.5K | $318K | 0.3% | New |
| SOC SABLE OFFSHORE CORP | Energy | 19.0K | $314K | 0.3% | Held |
| TMQ TRILOGY METALS INC | Materials | 87.0K | $312K | 0.3% | Held |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 15, 2026 | 138 | $102.9M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 17, 2026 | 123 | $120.4M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 14, 2025 | 136 | $115.6M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 14, 2025 | 77 | $83.8M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 14, 2025 | 77 | $93.4M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 12, 2025 | 82 | $111.4M | canonical | SEC ↗ |
Similar funds
DIAMANT ASSET MANAGEMENT, INC. LILLY ENDOWMENT INCBROOKFIELD Corp /ON/GQG Partners LLCMITSUBISHI UFJ FINANCIAL GROUP INCNewport Trust Company, LLCVIKING GLOBAL INVESTORS LPPARNASSUS INVESTMENTS, LLC MASTERCARD FOUNDATION ASSET MANAGEMENT CORPPZENA INVESTMENT MANAGEMENT LLCCOATUE MANAGEMENT LLCWinslow Capital Management, LLC